New arsenal against drug-resistant cancers

New arsenal against drug-resistant cancers

Combining camptothecin, a well-known anticancer alkaloid, with veliparib, an anticancer agent still under clinical trial, researchers have reported good results in treating drug-defying cancers of the breast, ovary, lungs and colon1. The combination therapy kills the cancer cells by inhibiting the activity of two key enzymes that orchestrate DNA replication, protein synthesis and DNA repairRead more about New arsenal against drug-resistant cancers[…]

Did humans acquire common cold virus from camels?

Did humans acquire common cold virus from camels?

Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) are coronaviruses that can infect and kill humans. A new study sheds light on their origins and ecological history, which thus far have been largely unknown. By sequencing and comparing the genes of coronaviruses in dromedary camels, bats and humans, an international research teamRead more about Did humans acquire common cold virus from camels?[…]